Director/PDMR Shareholding

Marwyn Value Investors Limited
29 September 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 213800L5751QTTVEA774

29 September 2023

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

SHARE DEALINGS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY ("PDMR")

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 ("MAR"), as incorporated by the European Union (Withdrawal) Act 2018, as amended ("UK MAR").

The Company today announces that it was notified that on 28 September that James Corsellis and Antoinette Vanderpuije, both partners of Marwyn Investment Management LLP, the manager of the Company, and Peter Rioda, Independent Non-Executive Director of the Company, purchased Ordinary Shares in the Company as follows:


Ordinary Shares Acquired

Purchase Price

Total Ordinary Shares held*

Total % Voting Rights Held

James Corsellis

34,080

£0.845

5,462,391

9.62%

Antoinette Vanderpuije

5,920

£0.845

222,112

0.39%

Peter Rioda

10,000

£0.845

20,000

0.04%

*Total Ordinary Shares held by James Corsellis and Antoinette Vanderpuije include both those held directly and those beneficially owned through an indirect holding in Marwyn Long Term Incentive LP

Whilst neither James Corsellis nor Antoinette Vanderpuije are Persons Discharging Managerial Responsibility ("PDMR") within the meaning of UK MAR, as amended in relation to the Company, they have voluntarily disclosed the information above to the Company, and the Company is voluntarily disclosing the information above to the market, as if they were PDMRs in relation to the Company.

Company enquiries:

Company Secretary - Aztec Financial Services (Jersey) Limited

Chris Copperwaite / Magdala Mullegadoo

Telephone: 01534 833000

 

Investor Relations

Kam Bansil

Telephone: 020 7039 1901

 

PR Adviser - FGS Global
Rollo Head 07768 994987
Chris Sibbald 07855 955531

 

Corporate Broker - Liberum Capital Limited

Chris Clarke / Owen Matthews

Telephone: 0203 100 2200

 

Shares in the Company are not designed or intended for retail investors. Marwyn Investment Management LLP, the Manager, does not promote shares in the Company to retail investors and they should not be offered to retail investors.

ANNEX

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Peter Rioda

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Independent Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Marwyn Value Investors Limited

b)

 

LEI

 

 

213800L5751QTTVEA774

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares



Identification code

MVI



b)

 

Nature of the transaction

 

 

Purchase of Shares

c)

 

Price(s) and volume(s)

 Price(s)

 Volumes(s)


 84.5 pence per share

 

 10,000

 

d)

 

Aggregated information

As in 4 c) above



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

28 September 2023

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings